Cargando…

Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series

With the aim to obtain novel compounds possessing both strong affinity against human carbonic anhydrases and low toxicity, we synthesised novel thiourea and sulphonamide derivatives 3, 4 and 10, and studied their in vitro inhibitory properties against human CA I, CA II and CA IX. We also evaluated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Aspatwar, Ashok, Parvathaneni, Nanda Kumar, Barker, Harlan, Anduran, Emilie, Supuran, Claudiu T., Dubois, Ludwig, Lambin, Philippe, Parkkila, Seppo, Winum, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844379/
https://www.ncbi.nlm.nih.gov/pubmed/31687859
http://dx.doi.org/10.1080/14756366.2019.1685510
_version_ 1783468423941980160
author Aspatwar, Ashok
Parvathaneni, Nanda Kumar
Barker, Harlan
Anduran, Emilie
Supuran, Claudiu T.
Dubois, Ludwig
Lambin, Philippe
Parkkila, Seppo
Winum, Jean-Yves
author_facet Aspatwar, Ashok
Parvathaneni, Nanda Kumar
Barker, Harlan
Anduran, Emilie
Supuran, Claudiu T.
Dubois, Ludwig
Lambin, Philippe
Parkkila, Seppo
Winum, Jean-Yves
author_sort Aspatwar, Ashok
collection PubMed
description With the aim to obtain novel compounds possessing both strong affinity against human carbonic anhydrases and low toxicity, we synthesised novel thiourea and sulphonamide derivatives 3, 4 and 10, and studied their in vitro inhibitory properties against human CA I, CA II and CA IX. We also evaluated the toxicity of these compounds using zebrafish larvae. Among the three compounds, derivative 4 showed efficient inhibition against hCA II (KI = 58.6 nM). Compound 10 showed moderate inhibition against hCA II (KI = 199.2 nM) and hCA IX (KI = 147.3 nM), whereas it inhibited hCA I less weakly at micromolar concentrations (KI = 6428.4 nM). All other inhibition constants for these compounds were in the submicromolar range. The toxicity evaluation studies showed no adverse effects on the zebrafish larvae. Our study suggests that these compounds are suitable for further preclinical characterisation as potential inhibitors of hCA I, II and IX.
format Online
Article
Text
id pubmed-6844379
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-68443792019-11-18 Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series Aspatwar, Ashok Parvathaneni, Nanda Kumar Barker, Harlan Anduran, Emilie Supuran, Claudiu T. Dubois, Ludwig Lambin, Philippe Parkkila, Seppo Winum, Jean-Yves J Enzyme Inhib Med Chem Research Paper With the aim to obtain novel compounds possessing both strong affinity against human carbonic anhydrases and low toxicity, we synthesised novel thiourea and sulphonamide derivatives 3, 4 and 10, and studied their in vitro inhibitory properties against human CA I, CA II and CA IX. We also evaluated the toxicity of these compounds using zebrafish larvae. Among the three compounds, derivative 4 showed efficient inhibition against hCA II (KI = 58.6 nM). Compound 10 showed moderate inhibition against hCA II (KI = 199.2 nM) and hCA IX (KI = 147.3 nM), whereas it inhibited hCA I less weakly at micromolar concentrations (KI = 6428.4 nM). All other inhibition constants for these compounds were in the submicromolar range. The toxicity evaluation studies showed no adverse effects on the zebrafish larvae. Our study suggests that these compounds are suitable for further preclinical characterisation as potential inhibitors of hCA I, II and IX. Taylor & Francis 2019-11-05 /pmc/articles/PMC6844379/ /pubmed/31687859 http://dx.doi.org/10.1080/14756366.2019.1685510 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Aspatwar, Ashok
Parvathaneni, Nanda Kumar
Barker, Harlan
Anduran, Emilie
Supuran, Claudiu T.
Dubois, Ludwig
Lambin, Philippe
Parkkila, Seppo
Winum, Jean-Yves
Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series
title Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series
title_full Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series
title_fullStr Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series
title_full_unstemmed Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series
title_short Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series
title_sort design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases i, ii and ix inhibitors in 5-nitroimidazole series
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844379/
https://www.ncbi.nlm.nih.gov/pubmed/31687859
http://dx.doi.org/10.1080/14756366.2019.1685510
work_keys_str_mv AT aspatwarashok designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries
AT parvathaneninandakumar designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries
AT barkerharlan designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries
AT anduranemilie designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries
AT supuranclaudiut designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries
AT duboisludwig designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries
AT lambinphilippe designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries
AT parkkilaseppo designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries
AT winumjeanyves designsynthesisinvitroinhibitionandtoxicologicalevaluationofhumancarbonicanhydrasesiiiandixinhibitorsin5nitroimidazoleseries